Urology
Volume 68, Issue 3, Supplement , Pages 1-5, September 2006

Introduction

  • John P. Mulhall

      Affiliations

    • Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA, and Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    • John P. Mulhall receives grant support from Pfizer Inc.
    • Corresponding Author InformationReprint requests: John P. Mulhall, MD, Department of Urology, Weill Medical College of Cornell University, New York Presbyterian Hospital and Memorial Sloan-Kettering Cancer Center, 525 East 68th Street, New York, NY 10021.
    • ,
  • Francesco Montorsi

      Affiliations

    • Department of Urology, Università Vita e Salute San Raffaele, Milan, Italy
    • Francesco Montorsi is a paid consultant to, and is partially funded by, Pfizer Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)00619-4

doi:10.1016/j.urology.2006.04.041

Urology
Volume 68, Issue 3, Supplement , Pages 1-5, September 2006

Article Tools